Is ‘man-flu’ real or just a joke? Know whether men truly experience colds and flu more severely — and what science says about ...

A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with ...

A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL ...

STAT Wunderkind Sydney Ramirez is revealing the immune system in our nasal passages and working toward better disease ...

ACTM-838 showed durable anti-tumor efficacy in multiple murine tumor models and synergized with anti-PD1 therapy in ...

CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company, ...

Investing.com -- CERo Therapeutics (NASDAQ:CERO), a T cell therapy biotech company, is open to licensing deals or a potential sale while awaiting data on its lead asset, according to Axios, citing CEO ...

Children and teenagers are more vulnerable to meningitis than adults because their immune systems are still developing, ...

This review examines how Western dietary patterns, high in ultra-processed foods, salt, and unhealthy fats, disrupt gut ...